Predica’s patent granted in AU

Predica’s patent on targeted RNA sequencing has been granted in one of the major territories: Australia.

Australia is making huge progress in the elimination of cervical cancer by reducing cervical cancer incidence, increasing HPV vaccine coverage and treatment of cervical pre-cancer (2023 Cervical Cancer Elimination Progress Report | C4).

With Predica’s technology, we will support elimination of cervical cancer and other Women’s Health related diseases.

Please contact us if you are interested to learn more about our developments